04/24/2024 3:05 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A | |
03/11/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:02 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/11/2024 6:03 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:38 PM | Sarepta Therapeutics (Subject) Wigzell Hans Lennart Rudolf (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Boor Kathryn Jean (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:00 PM | Nicaise Claude (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:34 PM | Mayo Stephen (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 6:55 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 6:42 PM | Estepan Ian Michael (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 3:47 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 12:34 PM | JANUS HENDERSON GROUP PLC (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024 4:26 PM | BlackRock Inc. (Filed by) Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024 11:08 AM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 7:00 PM | Arif Bilal (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 7:00 PM | Rodino-Klapac Louise (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | BEHRENS M KATHLEEN (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | INGRAM DOUGLAS S (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:00 AM | Barry Richard (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 7:00 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 7:00 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 6:40 AM | Chambers Michael Andrew (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 7:00 PM | Sarepta Therapeutics (Issuer) Wigzell Hans Lennart Rudolf (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Move Your Money Before May 1 (Ad) Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. |
08/04/2023 5:25 PM | Sarepta Therapeutics (Subject) Wigzell Hans Lennart Rudolf (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023 3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023 3:49 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2023 1:22 PM | Sarepta Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 7:00 PM | Brown Ryan Edward (Reporting) Sarepta Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |